Trevena (TRVN) Competitors $0.91 0.00 (0.00%) As of 07/23/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock TRVN vs. ONVO, GLMD, CERO, GENE, LIPO, ENVB, SXTP, UBX, PBM, and ARAVShould you be buying Trevena stock or one of its competitors? The main competitors of Trevena include Organovo (ONVO), Galmed Pharmaceuticals (GLMD), CERo Therapeutics (CERO), Genetic Technologies (GENE), Lipella Pharmaceuticals (LIPO), Enveric Biosciences (ENVB), 60 Degrees Pharmaceuticals (SXTP), UNITY Biotechnology (UBX), Psyence Biomedical (PBM), and Aravive (ARAV). These companies are all part of the "pharmaceutical products" industry. Trevena vs. Its Competitors Organovo Galmed Pharmaceuticals CERo Therapeutics Genetic Technologies Lipella Pharmaceuticals Enveric Biosciences 60 Degrees Pharmaceuticals UNITY Biotechnology Psyence Biomedical Aravive Organovo (NASDAQ:ONVO) and Trevena (NASDAQ:TRVN) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations and media sentiment. Does the media refer more to ONVO or TRVN? In the previous week, Organovo's average media sentiment score of 0.00 equaled Trevena'saverage media sentiment score. Company Overall Sentiment Organovo Neutral Trevena Neutral Is ONVO or TRVN more profitable? Trevena has a net margin of 0.00% compared to Organovo's net margin of -10,151.64%. Trevena's return on equity of 0.00% beat Organovo's return on equity.Company Net Margins Return on Equity Return on Assets Organovo-10,151.64% -346.26% -187.53% Trevena N/A N/A -119.55% Which has more risk and volatility, ONVO or TRVN? Organovo has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Trevena has a beta of 0.61, meaning that its stock price is 39% less volatile than the S&P 500. Do insiders and institutionals hold more shares of ONVO or TRVN? 8.2% of Organovo shares are held by institutional investors. Comparatively, 13.6% of Trevena shares are held by institutional investors. 3.7% of Organovo shares are held by insiders. Comparatively, 2.7% of Trevena shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has better earnings and valuation, ONVO or TRVN? Organovo has higher earnings, but lower revenue than Trevena. Trevena is trading at a lower price-to-earnings ratio than Organovo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrganovo$122K0.00-$14.67M-$10.20N/ATrevena$443K1.97-$40.29M-$47.04-0.02 Do analysts rate ONVO or TRVN? Trevena has a consensus target price of $5.00, suggesting a potential upside of 449.45%. Given Trevena's stronger consensus rating and higher possible upside, analysts clearly believe Trevena is more favorable than Organovo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organovo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Trevena 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryTrevena beats Organovo on 8 of the 12 factors compared between the two stocks. Get Trevena News Delivered to You Automatically Sign up to receive the latest news and ratings for TRVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TRVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRVN vs. The Competition Export to ExcelMetricTrevenaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$873K$772.90M$5.70B$9.48BDividend YieldN/A4.84%4.59%3.99%P/E Ratio-0.021.3827.9019.95Price / Sales1.9724.93442.19102.72Price / CashN/A19.5636.5558.97Price / Book-0.086.818.635.90Net Income-$40.29M-$4.28M$3.24B$258.42M7 Day PerformanceN/A1.99%3.22%1.94%1 Month Performance-19.25%4.61%10.72%12.02%1 Year Performance-83.84%9.43%34.94%20.81% Trevena Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRVNTrevena1.2701 of 5 stars$0.91flat$5.00+449.5%-83.9%$873K$443K-0.0240Positive NewsONVOOrganovoN/AN/AN/AN/A$3.47M$122K-2.4020Gap UpGLMDGalmed Pharmaceuticals0.9475 of 5 stars$2.09+8.0%N/A-50.7%$3.45MN/A-0.1320Positive NewsCEROCERo Therapeutics3.4613 of 5 stars$8.67-0.6%$45.00+419.0%-97.9%$3.38MN/A0.008Positive NewsGap DownGENEGenetic TechnologiesN/A$0.77flatN/AN/A$3.37M$7.66M0.0050Upcoming EarningsHigh Trading VolumeLIPOLipella Pharmaceuticals2.1069 of 5 stars$0.75-9.5%N/A-80.1%$3.36M$536.36K-0.184Gap DownENVBEnveric Biosciences2.5292 of 5 stars$1.34+2.3%$10.00+646.3%-79.8%$3.31MN/A-0.0320News CoveragePositive NewsSXTP60 Degrees Pharmaceuticals2.23 of 5 stars$2.16-14.3%$7.00+224.1%+45.3%$3.18M$665.45K-0.043High Trading VolumeUBXUNITY Biotechnology4.1356 of 5 stars$0.18-40.4%$3.75+1,995.0%-87.7%$3.08MN/A-0.1160Positive NewsGap DownHigh Trading VolumePBMPsyence Biomedical0.4081 of 5 stars$5.36+4.3%N/A-96.6%$3.06MN/A0.00N/APositive NewsGap UpTrading HaltedARAVAraviveN/A$0.04flatN/AN/A$2.95M$9.14M0.0020High Trading Volume Related Companies and Tools Related Companies ONVO Alternatives GLMD Alternatives CERO Alternatives GENE Alternatives LIPO Alternatives ENVB Alternatives SXTP Alternatives UBX Alternatives PBM Alternatives ARAV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TRVN) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevena, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevena With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRVN Stock Alerts